Analytic review: Neurological complications of transplantation

Journal of Intensive Care Medicine

Volumn 26, Issue 4, 2011, Pages 209-222

  Pustavoitau, Aliaksei ^a   Bhardwaj, Anish ^b   Stevens, Robert ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

brain tumors; encephalitis; encephalopathy; immune suppression; myopathy; organ transplantation; polyneuropathy; stroke

Indexed keywords

ACICLOVIR; ALEMTUZUMAB; AMPHOTERICIN B; AMPICILLIN; AZATHIOPRINE; CASPOFUNGIN; CORTICOSTEROID; COTRIMOXAZOLE; CYCLOSPORIN; CYCLOSPORIN A; EVEROLIMUS; FOSCARNET; FOSPHENYTOIN SODIUM; GANCICLOVIR; GLUCOCORTICOID; ITRACONAZOLE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; PHENYTOIN; PYRIMETHAMINE SULFADIAZINE; RAPAMYCIN; RIFAMPICIN; RITUXIMAB; TACROLIMUS; THYMOCYTE ANTIBODY; VALPROIC ACID; VORICONAZOLE; IMMUNOSUPPRESSIVE AGENT;

ASEPTIC MENINGITIS; BACTERIAL INFECTION; BRAIN EDEMA; BRAIN INFECTION; CENTRAL NERVOUS SYSTEM TUMOR; CENTRAL PONTINE MYELINOLYSIS; COMA; DELIRIUM; DIARRHEA; DRUG WITHDRAWAL; DYSPNEA; EXTRAPYRAMIDAL SYNDROME; FEVER; FLU LIKE SYNDROME; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HIGH RISK PATIENT; HOSPITAL ADMISSION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTENSIVE CARE UNIT; MANIA; MOOD DISORDER; MUSCLE WEAKNESS; MYALGIA; MYCOSIS; MYELITIS; MYOPATHY; NAUSEA; NERVE CELL LESION; NEUROIMAGING; NEUROLOGICAL COMPLICATION; NEUROMUSCULAR DISEASE; NEUROTOXICITY; NONHODGKIN LYMPHOMA; NONHUMAN; ORGAN TRANSPLANTATION; POLYNEUROPATHY; POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; PROTOZOAL INFECTION; PSYCHOSIS; RECIPIENT; REVIEW; RISK BENEFIT ANALYSIS; SEIZURE; SENSORIMOTOR NEUROPATHY; STROKE; SYMPTOM; TACHYCARDIA; VIRUS INFECTION; BRAIN TUMOR; MUSCLE DISEASE; NEUROLOGIC DISEASE; RISK;

BRAIN NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTENSIVE CARE UNITS; MUSCULAR DISEASES; NERVOUS SYSTEM DISEASES; ORGAN TRANSPLANTATION; RISK; STROKE;

EID: 80052099889     PISSN: 08850666     EISSN: 15251489     Source Type: Journal    
DOI: 10.1177/0885066610389549     Document Type: Review

References (193)

1. Patchell RA, White CL III, Clark AW, Beschorner WE, Santos GW Neurologic complications of bone marrow transplantation. Neurology. 1985 ; 35 (3). 300-306. (Pubitemid 15100666)
2. Adams DH, Ponsford S., Gunson B., et al. Neurological complications following liver transplantation. Lancet. 1987 ; 1 (8539). 949-951. (Pubitemid 17068583)
3. Graus F., Saiz A., Sierra J., et al. Neurologic complications of autologous and allogeneic bone marrow transplantation in patients with leukemia: a comparative study. Neurology. 1996 ; 46 (4). 1004-1009. (Pubitemid 26134642)
4. Antonini G., Ceschin V., Morino S., et al. Early neurologic complications following allogeneic bone marrow transplant for leukemia: a prospective study. Neurology. 1998 ; 50 (5). 1441-1445. (Pubitemid 28240367)
5. Sostak P., Padovan CS, Yousry TA, Ledderose G., Kolb HJ, Straube A. Prospective evaluation of neurological complications after allogeneic bone marrow transplantation. Neurology. 2003 ; 60 (5). 842-848. (Pubitemid 36297371)
6. Stein DP, Lederman RJ, Vogt DP, Carey WD, Broughan TA Neurological complications following liver transplantation. Ann Neurol. 1992 ; 31 (6). 644-649.
7. Guarino M., Stracciari A., Pazzaglia P., et al. Neurological complications of liver transplantation. J Neurol. 1996 ; 243 (2). 137-142. (Pubitemid 26026648)
8. Bleggi-Torres LF, de Medeiros BC, Werner B., et al. Neuropathological findings after bone marrow transplantation: an autopsy study of 180 cases. Bone Marrow Transplant. 2000 ; 25 (3). 301-307. (Pubitemid 30103020)
9. Martinez AJ The neuropathology of organ transplantation: comparison and contrast in 500 patients. Pathol Res Pract. 1998 ; 194 (7). 473-486. (Pubitemid 28393712)
10. Ferreiro JA, Robert MA, Townsend J., Vinters HV Neuropathologic findings after liver transplantation. Acta Neuropathol. 1992 ; 84 (1). 1-14.
11. Blanco R., De Girolami U., Jenkins RL, Khettry U. Neuropathology of liver transplantation. Clin Neuropathol. 1995 ; 14 (2). 109-117.
12. Ang LC, Gillett JM, Kaufmann JC Neuropathology of heart transplantation. Can J Neurol Sci. 1989 ; 16 (3). 291-298. (Pubitemid 19213589)
13. Sadaghdar H., Chelluri L., Bowles SA, Shapiro R. Outcome of renal transplant recipients in the ICU. Chest. 1995 ; 107 (5). 1402-1405.
14. Paz HL, Crilley P., Weinar M., Brodsky I. Outcome of patients requiring medical ICU admission following bone marrow transplantation. Chest. 1993 ; 104 (2). 527-531. (Pubitemid 23229528)
15. Price KJ, Thall PF, Kish SK, Shannon VR, Andersson BS Prognostic indicators for blood and marrow transplant patients admitted to an intensive care unit. Am J Respir Crit Care Med. 1998 ; 158 (3). 876-884. (Pubitemid 28449455)
16. Kogan A., Singer P., Cohen J., et al. Readmission to an intensive care unit following liver and kidney transplantation: a 50-month study. Transplant Proc. 1999 ; 31 (4). 1892-1893. (Pubitemid 29275498)
17. Levy MF, Greene L., Ramsay MA, et al. Readmission to the intensive care unit after liver transplantation. Crit Care Med. 2001 ; 29 (1). 18-24. (Pubitemid 32125768)
18. Afessa B., Tefferi A., Dunn WF, Litzow MR, Peters SG. Intensive care unit support and Acute Physiology and Chronic Health Evaluation III performance in hematopoietic stem cell transplant recipients. Crit Care Med. 2003 ; 31 (6). 1715-1721. (Pubitemid 36714227)
19. Hadjiliadis D., Steele MP, Govert JA, Davis RD, Palmer SM Outcome of lung transplant patients admitted to the medical ICU. Chest. 2004 ; 125 (3). 1040-1045. (Pubitemid 38367298)
20. Lim Z., Pagliuca A., Simpson S., et al. Outcomes of patients with haematological malignancies admitted to intensive care unit. A comparative review of allogeneic haematopoietic stem cell transplantation data. Br J Haematol. 2007 ; 136 (3). 448-450. (Pubitemid 46046303)
21. Pene F., Aubron C., Azoulay E., et al. Outcome of critically ill allogeneic hematopoietic stem-cell transplantation recipients: a reappraisal of indications for organ failure supports. J Clin Oncol. 2006 ; 24 (4). 643-649. (Pubitemid 46630428)
22. Gonzalez-Castro A., Suberviola B., Llorca J., Gonzalez-Mansilla C., Ortiz-Melon F., Minambres E. Prognosis factors in lung transplant recipients readmitted to the intensive care unit. Transplant Proc. 2007 ; 39 (7). 2420-2421. (Pubitemid 47418166)
23. Hamadah A., McDiarmid SA, Huebsch LB, Patel R., Allan DS Management of patients transferred to the ICU during the conditioning phase of allogeneic hematopoietic stem cell transplantation. Intensive Care Med. 2009 ; 35 (11). 2002-2003.
24. Klouche K., Amigues L., Massanet P., et al. Outcome of renal transplant recipients admitted to an intensive care unit: a 10-year cohort study. Transplantation. 2009 ; 87 (6). 889-895.
25. Tenza E., Bernardo CG, Escudero D., et al. Liver transplantation complications in the intensive care unit and at 6 months. Transplant Proc. 2009 ; 41 (3). 1050-1053.
26. Bustamante J., Rimola A., Ventura PJ, et al. Prognostic significance of hepatic encephalopathy in patients with cirrhosis. J Hepatol. 1999 ; 30 (5). 890-895. (Pubitemid 29248991)
27. Murray KF, Carithers RL Jr. AASLD practice guidelines: evaluation of the patient for liver transplantation. Hepatology. 2005 ; 41 (6). 1407-1432. (Pubitemid 40770295)
28. O'Grady JG, Alexander GJ, Hayllar KM, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology. 1989 ; 97 (2). 439-445. (Pubitemid 19192181)
29. Bernuau J., Goudeau A., Poynard T., et al. Multivariate analysis of prognostic factors in fulminant hepatitis B. Hepatology. 1986 ; 6 (4). 648-651. (Pubitemid 16038182)
30. Rovira A., Minguez B., Aymerich FX, et al. Decreased white matter lesion volume and improved cognitive function after liver transplantation. Hepatology. 2007 ; 46 (5). 1485-1490. (Pubitemid 350155530)
31. Lacerda SS, Guimaro MS, Prade CV, Ferraz-Neto BH, Karam CH, Andreoli PB Neuropsychological assessment in kidney and liver transplantation candidates. Transplant Proc. 2008 ; 40 (3). 729-731. (Pubitemid 351608646)
32. Meyer T., Eshelman A., Abouljoud M. Neuropsychological changes in a large sample of liver transplant candidates. Transplant Proc. 2006 ; 38 (10). 3559-3560. (Pubitemid 44908437)
33. Noriega-Sanchez A., Martinez-Maldonado M., Haiffe RM Clinical and electroencephalographic changes in progressive uremic encephalopathy. Neurology. 1978 ; 28 (7). 667-669. (Pubitemid 8364271)
34. Basile C., Miller JD, Koles ZJ, Grace M., Ulan RA The effects of dialysis on brain water and EEG in stable chronic uremia. Am J Kidney Dis. 1987 ; 9 (6). 462-469.
35. Andrykowski MA, Altmaier EM, Barnett RL, Burish TG, Gingrich R., Henslee-Downey PJ Cognitive dysfunction in adult survivors of allogeneic marrow transplantation: relationship to dose of total body irradiation. Bone Marrow Transplant. 1990 ; 6 (4). 269-276. (Pubitemid 20347882)
36. Andrykowski MA, Schmitt FA, Gregg ME, Brady MJ, Lamb DG, Henslee-Downey PJ Neuropsychologic impairment in adult bone marrow transplant candidates. Cancer. 1992 ; 70 (9). 2288-2297.
37. Dhar R., Young GB, Marotta P. Perioperative neurological complications after liver transplantation are best predicted by pre-transplant hepatic encephalopathy. Neurocrit Care. 2008 ; 8 (2). 253-258.
38. Sotil EU, Gottstein J., Ayala E., Randolph C., Blei AT Impact of preoperative overt hepatic encephalopathy on neurocognitive function after liver transplantation. Liver Transpl. 2009 ; 15 (2). 184-192.
39. Senzolo M., Pizzolato G., Ferronato C., et al. Long-term evaluation of cognitive function and cerebral metabolism in liver transplanted patients. Transplant Proc. 2009 ; 41 (4). 1295-1296.
40. Mechtcheriakov S., Graziadei IW, Mattedi M., et al. Incomplete improvement of visuo-motor deficits in patients with minimal hepatic encephalopathy after liver transplantation. Liver Transpl. 2004 ; 10 (1). 77-83. (Pubitemid 38885897)
41. Syrjala KL, Dikmen S., Langer SL, Roth-Roemer S., Abrams JR Neuropsychologic changes from before transplantation to 1 year in patients receiving myeloablative allogeneic hematopoietic cell transplant. Blood. 2004 ; 104 (10). 3386-3392. (Pubitemid 39507163)
42. Schulz-Kindermann F., Mehnert A., Scherwath A., et al. Cognitive function in the acute course of allogeneic hematopoietic stem cell transplantation for hematological malignancies. Bone Marrow Transplant. 2007 ; 39 (12). 789-799. (Pubitemid 46901978)
43. Abbott KC, Agodoa LY, O'Malley PG Hospitalized psychoses after renal transplantation in the United States: incidence, risk factors, and prognosis. J Am Soc Nephrol. 2003 ; 14 (6). 1628-1635. (Pubitemid 36687066)
44. Krahn LE, DiMartini A. Psychiatric and psychosocial aspects of liver transplantation. Liver Transpl. 2005 ; 11 (10). 1157-1168. (Pubitemid 41511926)
45. DiMartini A., Dew MA, Kormos R., McCurry K., Fontes P. Posttraumatic stress disorder caused by hallucinations and delusions experienced in delirium. Psychosomatics. 2007 ; 48 (5). 436-439.
46. Mueller AR, Platz KP, Bechstein WO, et al. Neurotoxicity after orthotopic liver transplantation. A comparison between cyclosporine and FK506. Transplantation. 1994 ; 58 (2). 155-170.
47. Wijdicks EF, Wiesner RH, Krom RA Neurotoxicity in liver transplant recipients with cyclosporine immunosuppression. Neurology. 1995 ; 45 (11). 1962-1964.
48. Small SL, Fukui MB, Bramblett GT, Eidelman BH Immunosuppression-induced leukoencephalopathy from tacrolimus (FK506). Ann Neurol. 1996 ; 40 (4). 575-580. (Pubitemid 26357881)
49. de Groen PC, Aksamit AJ, Rakela J., Forbes GS, Krom RA Central nervous system toxicity after liver transplantation. The role of cyclosporine and cholesterol. N Engl J Med. 1987 ; 317 (14). 861-866.
50. Appignani BA, Bhadelia RA, Blacklow SC, Wang AK, Roland SF, Freeman RB Jr. Neuroimaging findings in patients on immunosuppressive therapy: experience with tacrolimus toxicity. Am J Roentgenol. 1996 ; 166 (3). 683-688. (Pubitemid 26065184)
51. Hinchey J., Chaves C., Appignani B., et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med. 1996 ; 334 (8). 494-500. (Pubitemid 26067737)
52. Wong R., Beguelin GZ, de Lima M., et al. Tacrolimus-associated posterior reversible encephalopathy syndrome after allogeneic haematopoietic stem cell transplantation. Br J Haematol. 2003 ; 122 (1). 128-134. (Pubitemid 36819347)
53. Agildere AM, Basaran C., Cakir B., Ozgul E., Kural F., Haberal M. Evaluation of neurologic complications by brain MRI in kidney and liver transplant recipients. Transplant Proc. 2006 ; 38 (2). 611-618.
54. Casey SO, Sampaio RC, Michel E., Truwit CL Posterior reversible encephalopathy syndrome: utility of fluid-attenuated inversion recovery MR imaging in the detection of cortical and subcortical lesions. AJNR Am J Neuroradiol. 2000 ; 21 (7). 1199-1206. (Pubitemid 30655653)
55. Bartynski WS, Tan HP, Boardman JF, Shapiro R., Marsh JW Posterior reversible encephalopathy syndrome after solid organ transplantation. AJNR Am J Neuroradiol. 2008 ; 29 (5). 924-930. (Pubitemid 351684968)
56. Thompson CB, June CH, Sullivan KM, Thomas ED Association between cyclosporin neurotoxicity and hypomagnesaemia. Lancet. 1984 ; 2 (8412). 1116-1120. (Pubitemid 15210846)
57. Singh N., Bonham A., Fukui M. Immunosuppressive-associated leukoencephalopathy in organ transplant recipients. Transplantation. 2000 ; 69 (4). 467-472. (Pubitemid 30129574)
58. Dumont FJ, Staruch MJ, Koprak SL, et al. The immunosuppressive and toxic effects of FK-506 are mechanistically related: pharmacology of a novel antagonist of FK-506 and rapamycin. J Exp Med. 1992 ; 176 (3). 751-760.
59. Tronc F., Carrier M., Pelletier CL Mechanism of hind limb vasoconstriction due to cyclosporin A in the dog. Circ Res. 1992 ; 71 (5). 1159-1164.
60. McDonald JW, Goldberg MP, Gwag BJ, Chi SI, Choi DW Cyclosporine induces neuronal apoptosis and selective oligodendrocyte death in cortical cultures. Ann Neurol. 1996 ; 40 (5). 750-758. (Pubitemid 26415187)
61. Shuto H., Kataoka Y., Fujisaki K., et al. Inhibition of GABA system involved in cyclosporine-induced convulsions. Life Sci. 1999 ; 65 (9). 879-887. (Pubitemid 29400588)
62. Lieberman DN, Mody I. Regulation of NMDA channel function by endogenous Ca(2+)-dependent phosphatase. Nature. 1994 ; 369 (6477). 235-239. (Pubitemid 24154801)
63. Shuto H., Kataoka Y., Kanaya A., Matsunaga K., Sueyasu M., Oishi R. Enhancement of serotonergic neural activity contributes to cyclosporine-induced tremors in mice. Eur J Pharmacol. 1998 ; 341 (1). 33-37. (Pubitemid 28041195)
64. Guarino M., Benito-Leon J., Decruyenaere J., et al. EFNS guidelines on management of neurological problems in liver transplantation. Eur J Neurol. 2006 ; 13 (1). 2-9.
65. Maramattom BV, Wijdicks EF Sirolimus may not cause neurotoxicity in kidney and liver transplant recipients. Neurology. 2004 ; 63 (10). 1958-1959. (Pubitemid 39532403)
66. van de Beek D., Kremers WK, Kushwaha SS, McGregor CG, Wijdicks EF No major neurologic complications with sirolimus use in heart transplant recipients. Mayo Clin Proc. 2009 ; 84 (4). 330-332.
67. Forgacs B., Merhav HJ, Lappin J., Mieles L. Successful conversion to rapamycin for calcineurin inhibitor-related neurotoxicity following liver transplantation. Transplant Proc. 2005 ; 37 (4). 1912-1914. (Pubitemid 40790867)
68. Bodkin CL, Eidelman BH Sirolimus-induced posterior reversible encephalopathy. Neurology. 2007 ;68(23): 2039-2040.
69. Moskowitz A., Nolan C., Lis E., Castro-Malaspina H., Perales MA Posterior reversible encephalopathy syndrome due to sirolimus. Bone Marrow Transplant. 2007 ; 39 (10). 653-654. (Pubitemid 46722847)
70. Tsagalou EP, Anastasiou-Nana MI, Margari ZJ, Vassilopoulos D. Possible everolimus-induced, severe, reversible encephalopathy after cardiac transplantation. J Heart Lung Transplant. 2007 ; 26 (6). 661-664. (Pubitemid 46818045)
71. Lacomis D., Giuliani MJ, Van Cott A., Kramer DJ Acute myopathy of intensive care: clinical, electromyographic, and pathological aspects. Ann Neurol. 1996 ; 40 (4). 645-654. (Pubitemid 26357890)
72. Cosimi AB, Cho SI, Delmonico FL, Kaplan MM, Rohrer RJ, Jenkins RL A randomized clinical trial comparing OKT3 and steroids for treatment of hepatic allograft rejection. Transplantation. 1987 ; 43 (1). 91-95. (Pubitemid 17002463)
73. Millis JM, McDiarmid SV, Hiatt JR, et al. Randomized prospective trial of OKT3 for early prophylaxis of rejection after liver transplantation. Transplantation. 1989 ; 47 (1). 82-88. (Pubitemid 19049150)
74. Adair JC, Woodley SL, O'Connell JB, Call GK, Baringer JR Aseptic meningitis following cardiac transplantation: clinical characteristics and relationship to immunosuppressive regimen. Neurology. 1991 ; 41 (2pt1). 249-252.
75. Parizel PM, Snoeck HW, van den Hauwe L., et al. Cerebral complications of murine monoclonal CD3 antibody (OKT3): CT and MR findings. AJNR Am J Neuroradiol. 1997 ; 18 (10). 1935-1938. (Pubitemid 30413738)
76. Tzakis AG, Tryphonopoulos P., Kato T., et al. Preliminary experience with alemtuzumab (Campath-1H) and low-dose tacrolimus immunosuppression in adult liver transplantation. Transplantation. 2004 ; 77 (8). 1209-1214. (Pubitemid 38580299)
77. Gupta V., Ball SE, Sage D., et al. Marrow transplants from matched unrelated donors for aplastic anaemia using alemtuzumab, fludarabine and cyclophosphamide based conditioning. Bone Marrow Transplant. 2005 ; 35 (5). 467-471. (Pubitemid 40403349)
78. Clatworthy MR, Friend PJ, Calne RY, et al. Alemtuzumab (CAM-PATH-1H) for the treatment of acute rejection in kidney transplant recipients: long-term follow-up. Transplantation. 2009 ; 87 (7). 1092-1095.
79. Avivi I., Chakrabarti S., Kottaridis P., et al. Neurological complications following alemtuzumab-based reduced-intensity allogeneic transplantation. Bone Marrow Transplant. 2004 ; 34 (2). 137-142. (Pubitemid 39077104)
80. Vo AA, Lukovsky M., Toyoda M., et al. Rituximab and intravenous immune globulin for desensitization during renal transplantation. N Engl J Med. 2008 ; 359 (3). 242-251. (Pubitemid 352008439)
81. Becker YT, Becker BN, Pirsch JD, Sollinger HW Rituximab as treatment for refractory kidney transplant rejection. Am J Transplant. 2004 ; 4 (6). 996-1001. (Pubitemid 38745599)
82. Faguer S., Kamar N., Guilbeaud-Frugier C., et al. Rituximab therapy for acute humoral rejection after kidney transplantation. Transplantation. 2007 ; 83 (9). 1277-1280. (Pubitemid 46743692)
83. Usuda M., Fujimori K., Koyamada N., et al. Successful use of anti-CD20 monoclonal antibody (rituximab) for ABO-incompatible living-related liver transplantation. Transplantation. 2005 ; 79 (1). 12-16. (Pubitemid 40139994)
84. Genberg H., Kumlien G., Wennberg L., Berg U., Tyden G. ABO-incompatible kidney transplantation using antigen-specific immunoadsorption and rituximab: a 3-year follow-up. Transplantation. 2008 ; 85 (12). 1745-1754.
85. Carson KR, Evens AM, Richey EA, et al. Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project. Blood. 2009 ; 113 (20). 4834-4840.
86. Neuhaus P., Clavien PA, Kittur D., et al. Improved treatment response with basiliximab immunoprophylaxis after liver transplantation: results from a double-blind randomized placebo-controlled trial. Liver Transpl. 2002 ; 8 (2). 132-142. (Pubitemid 34202141)
87. Ponticelli C., Yussim A., Cambi V., et al. A randomized, double-blind trial of basiliximab immunoprophylaxis plus triple therapy in kidney transplant recipients. Transplantation. 2001 ; 72 (7). 1261-1267. (Pubitemid 33026606)
88. Hotson JR, Pedley TA The neurological complications of cardiac transplantation. Brain. 1976 ; 99 (4). 673-694. (Pubitemid 8162882)
89. Cemillan CA, Alonso-Pulpon L., Burgos-Lazaro R., Millan-Hernandez I., del Serl T., Liano-Martinez H. Neurological complications in a series of 205 orthotopic heart transplant patients. Revista de Neurologia. 2004 ; 38 (10). 906-912. (Pubitemid 38923947)
90. Perez-Miralles F., Sanchez-Manso JC, Almenar-Bonet L., Sevilla-Mantecon T., Martinez-Dolz L., Vilchez-Padilla JJ Incidence of and risk factors for neurologic complications after heart transplantation. Transplantation proceedings. 2005 ; 37 (9). 4067-4070. (Pubitemid 43015255)
91. van de Beek D., Patel R., Daly RC, McGregor CG, Wijdicks EF Central nervous system infections in heart transplant recipients. Arch Neurol. 2007 ; 64 (12). 1715-1720. (Pubitemid 350254932)
92. Jarquin-Valdivia AA, Wijdicks EF, McGregor C. Neurologic complications following heart transplantation in the modern era: decreased incidence, but postoperative stroke remains prevalent. Transplant Proc. 1999 ; 31 (5). 2161-2162. (Pubitemid 29376558)
93. Zierer A., Melby SJ, Voeller RK, et al. Significance of neurologic complications in the modern era of cardiac transplantation. Ann Thorac Surg. 2007 ; 83 (5). 1684-1690. (Pubitemid 46616776)
94. Malheiros SM, Almeida DR, Massaro AR, et al. Neurologic complications after heart transplantation. Arq Neuropsiquiatr. 2002 ; 60 (2-A). 192-197.
95. Goldstein LS, Haug MT III, Perl J. II, et al. Central nervous system complications after lung transplantation. J Heart Lung Transplant. 1998 ; 17 (2). 185-191. (Pubitemid 28103529)
96. Wong M., Mallory GB Jr, Goldstein J., Goyal M., Yamada KA Neurologic complications of pediatric lung transplantation. Neurology. 1999 ; 53 (7). 1542-1549. (Pubitemid 29491951)
97. Adams HP Jr, Dawson G., Coffman TJ, Corry RJ Stroke in renal transplant recipients. Arch Neurol. 1986 ; 43 (2). 113-115. (Pubitemid 16124233)
98. Ponticelli C., Campise MR Neurological complications in kidney transplant recipients. J Nephrol. 2005 ; 18 (5). 521-528. (Pubitemid 41824471)
99. Yardimci N., Colak T., Sevmis S., Benli S., Zileli T., Haberal M. Neurologic complications after renal transplant. Exp Clin Transplant. 2008 ; 6 (3). 224-228.
100. Saner F., Gu Y., Minouchehr S., et al. Neurological complications after cadaveric and living donor liver transplantation. J Neurol. 2006 ; 253 (5). 612-617. (Pubitemid 43876992)
101. Wijdicks EF, de Groen PC, Wiesner RH, Krom RA Intracerebral hemorrhage in liver transplant recipients. Mayo Clin Proc. 1995 ; 70 (5). 443-446.
102. Wang WL, Yang ZF, Lo CM, Liu CL, Fan ST Intracerebral hemorrhage after liver transplantation. Liver Transpl. 2000 ; 6 (3). 345-348.
103. Bronster DJ, Emre S., Boccagni P., Sheiner PA, Schwartz ME, Miller CM Central nervous system complications in liver transplant recipients-incidence, timing, and long-term follow-up. Clinical Transplant. 2000 ; 14 (1). 1-7. (Pubitemid 30079522)
104. Ardizzone G., Arrigo A., Schellino MM, et al. Neurological complications of liver cirrhosis and orthotopic liver transplant. Transplant Proc. 2006 ; 38 (3). 789-792. (Pubitemid 44389509)
105. Wijdicks EF, Torres VE, Schievink WI, Sterioff S. Cerebral hemorrhage in recipients of renal transplantation. Mayo Clin Proc. 1999 ; 74 (11). 1111-1112. (Pubitemid 30243244)
106. Andrews BT, Hershon JJ, Calanchini P., Avery GJ II, Hill JD Neurologic complications of cardiac transplantation. West J Med. 1990 ; 153 (2). 146-148. (Pubitemid 20257077)
107. Coplin WM, Cochran MS, Levine SR, Crawford SW Stroke after bone marrow transplantation: frequency, aetiology and outcome. Brain. 2001 ; 124 (pt5). 1043-1051. (Pubitemid 32458516)
108. Pomeranz S., Naparstek E., Ashkenazi E., et al. Intracranial haematomas following bone marrow transplantation. J Neurol. 1994 ; 241 (4). 252-256. (Pubitemid 24072939)
109. Nevo S., Swan V., Enger C., et al. Acute bleeding after bone marrow transplantation (BMT)-incidence and effect on survival. A quantitative analysis in 1,402 patients. Blood. 1998 ; 91 (4). 1469-1477. (Pubitemid 28086903)
110. Najima Y., Ohashi K., Miyazawa M., et al. Intracranial hemorrhage following allogeneic hematopoietic stem cell transplantation. Am J Hematol. 2009 ; 84 (5). 298-301.
111. McKinney AM, Short J., Truwit CL, et al. Posterior reversible encephalopathy syndrome: incidence of atypical regions of involvement and imaging findings. AJR Am J Roentgenol. 2007 ; 189 (4). 904-912. (Pubitemid 47485623)
112. Bartynski WS Posterior reversible encephalopathy syndrome, part 2: controversies surrounding pathophysiology of vasogenic edema. AJNR Am J Neuroradiol. 2008 ; 29 (6). 1043-1049. (Pubitemid 351954864)
113. Bartynski WS Posterior reversible encephalopathy syndrome, part 1: fundamental imaging and clinical features. AJNR Am J Neuroradiol. 2008 ; 29 (6). 1036-1042. (Pubitemid 351954863)
114. Bartynski WS, Zeigler ZR, Shadduck RK, Lister J. Pretransplantation conditioning influence on the occurrence of cyclosporine or FK-506 neurotoxicity in allogeneic bone marrow transplantation. AJNR Am J Neuroradiol. 2004 ; 25 (2). 261-269. (Pubitemid 38235306)
115. Siegal D., Keller A., Xu W., et al. Central nervous system complications after allogeneic hematopoietic stem cell transplantation: incidence, manifestations, and clinical significance. Biol Blood Marrow Transplant. 2007 ; 13 (11). 1369-1379. (Pubitemid 47571036)
116. Afzali B., Goldsmith DJ Successful retransplantation using rapamycin in a patient with previous calcineurin inhibitor-induced posterior leukoencephalopathy syndrome. Clin Nephrol. 2003 ; 59 (3). 225-228. (Pubitemid 36348264)
117. Covarrubias DJ, Luetmer PH, Campeau NG Posterior reversible encephalopathy syndrome: prognostic utility of quantitative diffusion-weighted MR images. AJNR Am J Neuroradiol. 2002 ; 23 (6). 1038-1048. (Pubitemid 34663453)
118. Donmez FY, Basaran C., Kayahan Ulu EM, Yildirim M., Coskun M. MRI features of posterior reversible encephalopathy syndrome in 33 patients. J Neuroimaging. 2010 ; 20 (1). 22-28.
119. Aranas RM, Prabhakaran S., Lee VH Posterior reversible encephalopathy syndrome associated with hemorrhage. Neurocrit Care. 2009 ; 10 (3). 306-312.
120. Hefzy HM, Bartynski WS, Boardman JF, Lacomis D. Hemorrhage in posterior reversible encephalopathy syndrome: imaging and clinical features. AJNR Am J Neuroradiol. 2009 ; 30 (7). 1371-1379.
121. Caillard S., Dharnidharka V., Agodoa L., Bohen E., Abbott K. Posttransplant lymphoproliferative disorders after renal transplantation in the United States in era of modern immunosuppression. Transplantation. 2005 ; 80 (9). 1233-1243. (Pubitemid 41746802)
122. Penn I., Porat G. Central nervous system lymphomas in organ allograft recipients. Transplantation. 1995 ; 59 (2). 240-244.
123. Snanoudj R., Durrbach A., Leblond V., et al. Primary brain lymphomas after kidney transplantation: presentation and outcome. Transplantation. 2003 ; 76 (6). 930-937. (Pubitemid 37186022)
124. Norin S., Kimby E., Ericzon BG, et al. Posttransplant lymphoma-a single-center experience of 500 liver transplantations. Med Oncol. 2004 ; 21 (3). 273-284. (Pubitemid 39469769)
125. Herzig KA, Juffs HG, Norris D., et al. A single-centre experience of post-renal transplant lymphoproliferative disorder. Transpl Int. 2003 ; 16 (7). 529-536. (Pubitemid 36975574)
126. Au WY, Lie AK, Kwong YL, et al. Post-transplantation lymphoproliferative disease in Chinese: the Queen Mary Hospital experience in Hong Kong. Leuk Lymphoma. 2002 ; 43 (7). 1403-1407. (Pubitemid 34705024)
127. Schiff D., O'Neill B., Wijdicks E., Antin JH, Wen PY Gliomas arising in organ transplant recipients: an unrecognized complication of transplantation? Neurology. 2001 ; 57 (8). 1486-1488. (Pubitemid 32995734)
128. Fatt MA, Horton KM, Fishman EK Transmission of metastatic glioblastoma multiforme from donor to lung transplant recipient. J Comput Assist Tomogr. 2008 ; 32 (3). 407-409.
129. Singh N., Husain S. Infections of the central nervous system in transplant recipients. Transpl Infect Dis. 2000 ; 2 (3). 101-111.
130. Fishman JA Infection in solid-organ transplant recipients. N Engl J Med. 2007 ; 357 (25). 2601-2614. (Pubitemid 350294226)
131. Hall WA, Martinez AJ, Dummer JS, et al. Central nervous system infections in heart and heart-lung transplant recipients. Arch Neurol. 1989 ; 46 (2). 173-177. (Pubitemid 19051268)
132. Wilson JP, Turner HR, Kirchner KA, Chapman SW Nocardial infections in renal transplant recipients. Medicine. 1989 ; 68 (1). 38-57. (Pubitemid 19041252)
133. Meyers BR, Halpern M., Sheiner P., Mendelson MH, Neibart E., Miller C. Tuberculosis in liver transplant patients. Transplantation. 1994 ; 58 (3). 301-306. (Pubitemid 24252281)
134. Grauhan O., Lohmann R., Lemmens P., et al. Mycobacterial infection after liver transplantation. Langenbecks Arch Chir. 1995 ; 380 (3). 171-175.
135. Meyers BR, Papanicolaou GA, Sheiner P., Emre S., Miller C. Tuberculosis in orthotopic liver transplant patients: increased toxicity of recommended agents; cure of disseminated infection with nonconventional regimens. Transplantation. 2000 ; 69 (1). 64-69. (Pubitemid 30062610)
136. Aguado JM, Herrero JA, Gavalda J., et al. Clinical presentation and outcome of tuberculosis in kidney, liver, and heart transplant recipients in Spain. Spanish Transplantation Infection Study Group, GESITRA. Transplantation. 1997 ; 63 (9). 1278-1286. (Pubitemid 27212823)
137. Kaaroud H., Beji S., Boubaker K., et al. Tuberculosis after renal transplantation. Transplant Proc. 2007 ; 39 (4). 1012-1013. (Pubitemid 46764833)
138. Mizuno S., Zendejas IR, Reed AI, et al. Listeria monocytogenes following orthotopic liver transplantation: central nervous system involvement and review of the literature. World J Gastroenterol. 2007 ; 13 (32). 4391-4393. (Pubitemid 47377149)
139. Armstrong RW, Fung PC Brainstem encephalitis (rhombencephalitis) due to Listeria monocytogenes: case report and review. Clin Infect Dis. 1993 ; 16 (5). 689-702. (Pubitemid 23136569)
140. Gentile G. Post-transplant HHV-6 diseases. Herpes. 2000 ; 7 (1). 24-27. (Pubitemid 30479580)
141. Vu T., Carrum G., Hutton G., Heslop HE, Brenner MK, Kamble R. Human herpesvirus-6 encephalitis following allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant. 2007 ; 39 (11). 705-709. (Pubitemid 46813587)
142. Nash PJ, Avery RK, Tang WH, Starling RC, Taege AJ, Yamani MH Encephalitis owing to human herpesvirus-6 after cardiac transplant. Am J Transplant. 2004 ; 4 (7). 1200-1203. (Pubitemid 38868616)
143. Zerr DM, Gooley TA, Yeung L., et al. Human herpesvirus 6 reactivation and encephalitis in allogeneic bone marrow transplant recipients. Clin Infect Dis. 2001 ; 33 (6). 763-771. (Pubitemid 32831831)
144. Rogers J., Rohal S., Carrigan DR, et al. Human herpesvirus-6 in liver transplant recipients: role in pathogenesis of fungal infections, neurologic complications, and outcome. Transplantation. 2000 ; 69 (12). 2566-2573. (Pubitemid 30482023)
145. Arribas JR, Storch GA, Clifford DB, Tselis AC Cytomegalovirus encephalitis. Ann Intern Med. 1996 ; 125 (7). 577-587. (Pubitemid 126450091)
146. Shitrit D., Lev N., Bar-Gil-Shitrit A., Kramer MR Progressive multifocal leukoencephalopathy in transplant recipients. Transpl Int. 2005 ; 17 (11). 658-665. (Pubitemid 40558222)
147. Bonham CA, Dominguez EA, Fukui MB, et al. Central nervous system lesions in liver transplant recipients: prospective assessment of indications for biopsy and implications for management. Transplantation. 1998 ; 66 (12). 1596-1604. (Pubitemid 29034977)
148. Selby R., Ramirez CB, Singh R., et al. Brain abscess in solid organ transplant recipients receiving cyclosporine-based immunosuppression. Arch Surg. 1997 ; 132 (3). 304-310. (Pubitemid 27136825)
149. Hagensee ME, Bauwens JE, Kjos B., Bowden RA Brain abscess following marrow transplantation: experience at the Fred Hutchinson Cancer Research Center, 1984-1992. Clin Infect Dis. 1994 ; 19 (3). 402-408. (Pubitemid 24286941)
150. Baddley JW, Salzman D., Pappas PG Fungal brain abscess in transplant recipients: epidemiologic, microbiologic, and clinical features. Clin Transplant. 2002 ; 16 (6). 419-424. (Pubitemid 36004273)
151. Boon AP, Adams DH, Buckels J., McMaster P. Cerebral aspergillosis in liver transplantation. J Clin Pathol. 1990 ; 43 (2). 114-118. (Pubitemid 20044029)
152. Herbrecht R., Denning DW, Patterson TF, et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med. 2002 ; 347 (6). 408-415. (Pubitemid 34851833)
153. Wu G., Vilchez RA, Eidelman B., Fung J., Kormos R., Kusne S. Cryptococcal meningitis: an analysis among 5,521 consecutive organ transplant recipients. Transplant Infect Dis. 2002 ; 4 (4). 183-188. (Pubitemid 36142803)
154. Jabbour N., Reyes J., Kusne S., Martin M., Fung J. Cryptococcal meningitis after liver transplantation. Transplantation. 1996 ; 61 (1). 146-149. (Pubitemid 26033392)
155. Sloan D., Dlamini S., Paul N., Dedicoat M. Treatment of acute cryptococcal meningitis in HIV infected adults, with an emphasis on resource-limited settings. Cochrane Database Syst Rev. 2008 ;(4). CD005647.
156. Maschke M., Dietrich U., Prumbaum M., et al. Opportunistic CNS infection after bone marrow transplantation. Bone Marrow Transplant. 1999 ; 23 (11). 1167-1176. (Pubitemid 29259674)
157. Arunkumar MJ, Rajshekhar V., Chandy MJ, Thomas PP, Jacob CK Management and outcome of brain abscess in renal transplant recipients. Postgrad Med J. 2000 ; 76 (894). 207-211. (Pubitemid 30192773)
158. Vukmir RB, Kusne S., Linden P., et al. Successful therapy for cerebral phaeohyphomycosis due to Dactylaria gallopava in a liver transplant recipient. Clin Infect Dis. 1994 ; 19 (4). 714-719. (Pubitemid 24301148)
159. Patel R., Gustaferro CA, Krom RA, Wiesner RH, Roberts GD, Paya CV Phaeohyphomycosis due to Scopulariopsis brumptii in a liver transplant recipient. Clin Infect Dis. 1994 ; 19 (1). 198-200. (Pubitemid 24227059)
160. Luft BJ, Naot Y., Araujo FG, Stinson EB, Remington JS Primary and reactivated toxoplasma infection in patients with cardiac transplants. Clinical spectrum and problems in diagnosis in a defined population. Ann Intern Med. 1983 ; 99 (1). 27-31. (Pubitemid 13066653)
161. Gourishankar S., Doucette K., Fenton J., Purych D., Kowalewska-Grochowska K., Preiksaitis J. The use of donor and recipient screening for toxoplasma in the era of universal trimethoprim sulfamethoxazole prophylaxis. Transplantation. 2008 ; 85 (7). 980-985. (Pubitemid 351543161)
162. Roemer E., Blau IW, Basara N., et al. Toxoplasmosis, a severe complication in allogeneic hematopoietic stem cell transplantation: successful treatment strategies during a 5-year single-center experience. Clin Infect Dis. 2001 ; 32 (1). E1 - E8.
163. Martino R., Maertens J., Bretagne S., et al. Toxoplasmosis after hematopoietic stem cell transplantation. Clin Infect Dis. 2000 ; 31 (5). 1188-1195.
164. Renoult E., Georges E., Biava MF, et al. Toxoplasmosis in kidney transplant recipients: report of six cases and review. Clin Infect Dis. 1997 ; 24 (4). 625-634. (Pubitemid 27143556)
165. Derouin F., Pelloux H; ESCMID Study Group on Clinical Parasitology. Prevention of toxoplasmosis in transplant patients. Clin Microbiol Infect. 2008 ; 14 (12). 1089-1101.
166. Torre D., Casari S., Speranza F., et al. Randomized trial of trimethoprim-sulfamethoxazole versus pyrimethamine-sulfadiazine for therapy of toxoplasmic encephalitis in patients with AIDS. Italian Collaborative Study Group. Antimicrob Agents Chemother. 1998 ; 42 (6). 1346-1349. (Pubitemid 28257629)
167. Baran DA, Alwarshetty MM, Alvi S., et al. Is toxoplasmosis prophylaxis necessary in cardiac transplantation? Long-term follow-up at two transplant centers. J Heart Lung Transplant. 2006 ; 25 (11). 1380-1382. (Pubitemid 44692500)
168. Chabolla DR, Harnois DM, Meschia JF Levetiracetam mono-therapy for liver transplant patients with seizures. Transplant Proc. 2003 ; 35 (4). 1480-1481. (Pubitemid 36765571)
169. Yun BC, Kim WR, Benson JT, et al. Impact of pretransplant hyponatremia on outcome following liver transplantation. Hepatology. 2009 ; 49 (5). 1610-1615.
170. Estol CJ, Faris AA, Martinez AJ, Ahdab-Barmada M. Central pontine myelinolysis after liver transplantation. Neurology. 1989 ; 39 (4). 493-498. (Pubitemid 19105761)
171. Boon AP, Carey MP, Adams DH, Buckels J., McMaster P. Central pontine myelinolysis in liver transplantation. J Clin Pathol. 1991 ; 44 (11). 909-914.
172. Abbasoglu O., Goldstein RM, Vodapally MS, et al. Liver transplantation in hyponatremic patients with emphasis on central pontine myelinolysis. Clin Transplant. 1998 ; 12 (3). 263-269. (Pubitemid 28269252)
173. Yu J., Zheng SS, Liang TB, Shen Y., Wang WL, Ke QH Possible causes of central pontine myelinolysis after liver transplantation. World J Gastroenterol. 2004 ; 10 (17). 2540-2543. (Pubitemid 39206775)
174. Adams RD, Victor M., Mancall EL Central pontine myelinolysis: a hitherto undescribed disease occurring in alcoholic and malnourished patients. AMA Arch Neurol Psychiatry. 1959 ; 81 (2). 154-172.
175. Zivkovic S. Neuroimaging and neurologic complications after organ transplantation J Neuroimaging. 2007 ; 17 (2). 110-123. (Pubitemid 46624151)
176. Wijdicks EF, Litchy WJ, Wiesner RH, Krom RA Neuromuscular complications associated with liver transplantation. Muscle Nerve. 1996 ; 19 (6). 696-700. (Pubitemid 26134578)
177. Campellone JV, Lacomis D., Kramer DJ, Van Cott AC, Giuliani MJ Acute myopathy after liver transplantation. Neurology. 1998 ; 50 (1). 46-53. (Pubitemid 128722716)
178. Mateen FJ, van de Beek D., Kremers WK, et al. Neuromuscular diseases after cardiac transplantation. J Heart Lung Transplant. 2009 ; 28 (3). 226-230.
179. Sharma KR, Cross J., Santiago F., Ayyar DR, Burke G. III. Incidence of acute femoral neuropathy following renal transplantation. Arch Neurol. 2002 ; 59 (4). 541-545. (Pubitemid 34289957)
180. Zhang L., Arrington S., Keung YK Guillain-Barre syndrome after transplantation. Leukemia Lymphoma. 2008 ; 49 (2). 291-297.
181. Snover DC Acute and chronic graft versus host disease: histopathological evidence for two distinct pathogenetic mechanisms. Hum Pathol. 1984 ; 15 (3). 202-205.
182. Padovan CS, Bise K., Hahn J., et al. Angiitis of the central nervous system after allogeneic bone marrow transplantation ? Stroke. 1999 ; 30 (8). 1651-1656. (Pubitemid 29379619)
183. Padovan CS, Yousry TA, Schleuning M., Holler E., Kolb HJ, Straube A. Neurological and neuroradiological findings in long-term survivors of allogeneic bone marrow transplantation. Ann Neurol. 1998 ; 43 (5). 627-633. (Pubitemid 28225554)
184. Kamble RT, Chang CC, Sanchez S., Carrum G. Central nervous system graft-versus-host disease: report of two cases and literature review. Bone Marrow Transplant. 2007 ; 39 (1). 49-52. (Pubitemid 44921654)
185. Parker P., Chao NJ, Ben-Ezra J., et al. Polymyositis as a manifestation of chronic graft-versus-host disease. Medicine. 1996 ; 75 (5). 279-285. (Pubitemid 26337847)
186. Stevens AM, Sullivan KM, Nelson JL Polymyositis as a manifestation of chronic graft-versus-host disease. Rheumatology. 2003 ; 42 (1). 34-39. (Pubitemid 36131564)
187. Mackey JR, Desai S., Larratt L., Cwik V., Nabholtz JM Myasthenia gravis in association with allogeneic bone marrow transplantation: clinical observations, therapeutic implications and review of literature. Bone Marrow Transplant. 1997 ; 19 (9). 939-942. (Pubitemid 27217663)
188. Zaja F., Barillari G., Russo D., Silvestri F., Fanin R., Baccarani M. Myasthenia gravis after allogeneic bone marrow transplantation. A case report and a review of the literature. Acta Neurol Scand. 1997 ; 96 (4). 256-259. (Pubitemid 27402495)
189. Smith CI, Norberg R., Moller G., Lonnqvist B., Hammarstrom L. Autoantibody formation after bone marrow transplantation. Comparison between acetylcholine receptor antibodies and other autoantibodies and analysis of HLA and Gm markers. Eur Neurol. 1989 ; 29 (3). 128-134. (Pubitemid 19139392)
190. Mayer TO, Biller J., O'Donnell J., et al. Contrasting the neurologic complications of cardiac transplantation in adults and children. J Child Neurol. 2002 ; 17 (3). 195-199. (Pubitemid 34704913)
191. Menegaux F., Keeffe EB, Andrews BT, et al. Neurological complications of liver transplantation in adult versus pediatric patients. Transplantation. 1994 ; 58 (4). 447-450. (Pubitemid 24271533)
192. Fonseca-Aten M., Michaels MG Infections in pediatric solid organ transplant recipients. Semin Pediatr Surg. 2006 ; 15 (3). 153-161. (Pubitemid 43963385)
193. Martin AB, Bricker JT, Fishman M., et al. Neurologic complications of heart transplantation in children. J Heart Lung Transplant. 1992 ; 11 (5). 933-942.